Citicoline drops may slow glaucoma progression in some patients

Adding citicoline eye drops to IOP-lowering medications might reduce glaucoma progression in patients with worsening damage despite well-controlled IOP, according to a study.
In a group of patients treated with citicoline, visual field (VF) progression was significantly reduced, and retinal nerve fiber layer (RNFL) loss was on average 1.86 µm at 3 years vs. 2.99 µm in patients treated with placebo.
“The question behind our investigation was whether supplementing the IOP-lowering therapy with a neuroprotective agent might help in the ‘well-controlled’ but

Full Story →